Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy

Background: We retrospectively evaluated the efficacy and toxicity of paclitaxel plus doxorubicin as a second-line treatment in patients with urothelial carcinoma, who had not responded to a prior platinum plus gemcitabine combination. Patients and Methods: All patients received intravenous infusion...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology research and treatment 2012-10, Vol.35 (10), p.576-580
Hauptverfasser:	Kaya, Ali O., Coskun, Ugur, Ozkan, Metin, Sevinc, Alper, Yilmaz, Ahmet U., Gumus, Mahmut, Unal, Olcun U., Ozdemir, Nuriye Y., Alici, Suleyman, Berk, Veli, Degerli, Hatice, Oner, Mehmet K., Ozturk, Cemil, Kefeli, Umut, Camcı, Celalettin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Carcinoma, Transitional Cell - diagnosis Carcinoma, Transitional Cell - drug therapy Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Doxorubicin - administration & dosage Humans Male Middle Aged Original Article · Originalarbeit Paclitaxel - administration & dosage Platinum - administration & dosage Premedication - methods Retrospective Studies Treatment Outcome Urinary Bladder Neoplasms - diagnosis Urinary Bladder Neoplasms - drug therapy Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!